Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Insulin Like Growth Factor I is a group of peptides with growth-promoting effects. Its secreting cells are widely distributed in human liver, kidney, lung, heart, brain and intestinal tissues. Insulin Like Growth Factor I is an important growth factor in childhood because of its strong growth-promoting effect. Insulin Like Growth Factor I synthesized in various tissues mostly plays its role of promoting growth by autocrine or paracrine.
At present, the industry competition of Insulin Like Growth Factor I is very fierce because of the fragmentation of the market. Despite the fragmentation of the market, Insulin Like Growth Factor I is still largely constrained by different regulatory requirements of the government. Utility owned industries are mainly driven by increasing financial incentives and regulatory support from governments around the world. At present, theInsulin Like Growth Factor I industry owned by utility companies is mainly affected by the COVID-19 pandemic.
The major driver of global market for Insulin Like Growth Factor I is the increasing incidence of rare diseases such as Alzheimer's disease, breast cancer, Huntington's disease, and muscular dystrophy due to the increasing environmental pollution worldwide. In addition, technological advances are also driving the growth of the Insulin Like Growth Factor I market.
The report details the trend, potential and market size of Insulin Like Growth Factor I market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Insulin Like Growth Factor Imarket, defines the market attractiveness level of Insulin Like Growth Factor I market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Insulin Like Growth Factor I industry, describes the types of Insulin Like Growth Factor I market, the applications of major players and the market size, and deeply analyzes the current situation of the global Insulin Like Growth Factor I market and the development prospects and opportunities of Insulin Like Growth Factor I industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Insulin Like Growth Factor I market in Chapter 13.
By Player:
MedImmune LLC
Regulaxis SAS
Genervon Biopharmaceuticals LLC
Boehringer Ingelheim GmbH
By Type:
CIGB-845
GM-6
M-61027
M-630
By End-User:
Alzheimer's Disease
Breast Cancer
Huntington Disease
Muscular Dystrophy
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Insulin Like Growth Factor I Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Insulin Like Growth Factor I Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Insulin Like Growth Factor I Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Insulin Like Growth Factor I Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Insulin Like Growth Factor I Market Analysis and Outlook to 2022
-
7.1 Global Insulin Like Growth Factor I Consumption (2017-2022)
-
7.2 United States Insulin Like Growth Factor I Consumption (2017-2022)
-
7.3 Europe Insulin Like Growth Factor I Consumption (2017-2022)
-
7.4 China Insulin Like Growth Factor I Consumption (2017-2022)
-
7.5 Japan Insulin Like Growth Factor I Consumption (2017-2022)
-
7.6 India Insulin Like Growth Factor I Consumption (2017-2022)
-
7.7 South Korea Insulin Like Growth Factor I Consumption (2017-2022)
8 Region and Country-wise Insulin Like Growth Factor I Market Analysis and Outlook to 2028
-
8.1 Global Insulin Like Growth Factor I Consumption Forecast (2022-2028)
-
8.2 United States Insulin Like Growth Factor I Consumption Forecast (2022-2028)
-
8.3 Europe Insulin Like Growth Factor I Consumption Forecast (2022-2028)
-
8.4 China Insulin Like Growth Factor I Consumption Forecast (2022-2028)
-
8.5 Japan Insulin Like Growth Factor I Consumption Forecast (2022-2028)
-
8.6 India Insulin Like Growth Factor I Consumption Forecast (2022-2028)
-
8.7 South Korea Insulin Like Growth Factor I Consumption Forecast (2022-2028)
9 Global Insulin Like Growth Factor I Market Outlook by Types and Applications to 2022
-
9.1 Global Insulin Like Growth Factor I Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global CIGB-845 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global GM-6 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global M-61027 Consumption and Growth Rate (2017-2022)
-
9.1.4 Global M-630 Consumption and Growth Rate (2017-2022)
-
9.2 Global Insulin Like Growth Factor I Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Huntington Disease Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Muscular Dystrophy Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Insulin Like Growth Factor I Market Outlook by Types and Applications to 2028
-
10.1 Global Insulin Like Growth Factor I Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global CIGB-845 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global GM-6 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global M-61027 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global M-630 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Insulin Like Growth Factor I Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Huntington Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Muscular Dystrophy Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Insulin Like Growth Factor I Import and Export Analysis (Top 5 Countries)
-
11.1 Global Insulin Like Growth Factor I Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Insulin Like Growth Factor I Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Insulin Like Growth Factor I Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Insulin Like Growth Factor I Market Competitive Analysis
-
14.1 MedImmune LLC
-
14.1.1 MedImmune LLC Company Details
-
14.1.2 MedImmune LLC Insulin Like Growth Factor I Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 MedImmune LLC Insulin Like Growth Factor I Product and Service
-
14.2 Regulaxis SAS
-
14.2.1 Regulaxis SAS Company Details
-
14.2.2 Regulaxis SAS Insulin Like Growth Factor I Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Regulaxis SAS Insulin Like Growth Factor I Product and Service
-
14.3 Genervon Biopharmaceuticals LLC
-
14.3.1 Genervon Biopharmaceuticals LLC Company Details
-
14.3.2 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Product and Service
-
14.4 Boehringer Ingelheim GmbH
-
14.4.1 Boehringer Ingelheim GmbH Company Details
-
14.4.2 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Insulin Like Growth Factor I
-
Figure Insulin Like Growth Factor I Picture
-
Table Global Insulin Like Growth Factor I Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Insulin Like Growth Factor I Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Insulin Like Growth Factor I Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Insulin Like Growth Factor I Consumption by Country (2017-2022)
-
Figure United States Insulin Like Growth Factor I Consumption and Growth Rate (2017-2022)
-
Table Europe Insulin Like Growth Factor I Consumption and Growth Rate (2017-2022)
-
Figure China Insulin Like Growth Factor I Consumption and Growth Rate (2017-2022)
-
Figure Japan Insulin Like Growth Factor I Consumption and Growth Rate (2017-2022)
-
Figure India Insulin Like Growth Factor I Consumption and Growth Rate (2017-2022)
-
Figure South Korea Insulin Like Growth Factor I Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Like Growth Factor I Consumption Forecast by Country (2022-2028)
-
Figure United States Insulin Like Growth Factor I Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Insulin Like Growth Factor I Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Insulin Like Growth Factor I Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Insulin Like Growth Factor I Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Insulin Like Growth Factor I Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Insulin Like Growth Factor I Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CIGB-845 Consumption and Growth Rate (2017-2022)
-
Figure Global GM-6 Consumption and Growth Rate (2017-2022)
-
Figure Global M-61027 Consumption and Growth Rate (2017-2022)
-
Figure Global M-630 Consumption and Growth Rate (2017-2022)
-
Figure Global Alzheimer's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Huntington Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Muscular Dystrophy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global CIGB-845 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global GM-6 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global M-61027 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global M-630 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Alzheimer's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Huntington Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Muscular Dystrophy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Insulin Like Growth Factor I Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Insulin Like Growth Factor I Export by Region (Top 5 Countries) (2017-2028)
-
Table MedImmune LLC (Foundation Year, Company Profile and etc.)
-
Table MedImmune LLC Insulin Like Growth Factor I Sales, Price, Value and Gross Profit (2017-2022)
-
Table MedImmune LLC Insulin Like Growth Factor I Product and Service
-
Table Regulaxis SAS (Foundation Year, Company Profile and etc.)
-
Table Regulaxis SAS Insulin Like Growth Factor I Sales, Price, Value and Gross Profit (2017-2022)
-
Table Regulaxis SAS Insulin Like Growth Factor I Product and Service
-
Table Genervon Biopharmaceuticals LLC (Foundation Year, Company Profile and etc.)
-
Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Product and Service
-
Table Boehringer Ingelheim GmbH (Foundation Year, Company Profile and etc.)
-
Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Sales, Price, Value and Gross Profit (2017-2022)
-
Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Product and Service
-
